Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
SHSE:600276
Jiangsu Hengrui Medicine
|
44.75 | 40,42% | 78,67% | 284.545,55 | 0,45% | 1,61% |
|
SZSE:000538
Yunnan Baiyao Group Co.,Ltd
|
55.31 | 91,49% | 100,48% | 100.792,99 | 3,76% | 1,42% |
|
SHSE:601607
Shanghai Pharmaceuticals Holding
|
18.46 | 51,43% | 74,37% | 60.286,59 | 2,22% | 0,63% |
|
SHSE:600196
Shanghai Fosun Pharmaceutical (Group)
|
23.78 | 90,1% | 181,68% | 58.251,4 | 1,14% | -2,01% |
|
SEHK:874
Guangzhou Baiyunshan Pharmaceutical
Holdings Company |
23.55 | 66,89% | 0% | 53.844,3 | 3,44% | 5,05% |
|
SHSE:600079
Humanwell Healthcare (Group)
|
20.28 | 7,17% | 26,49% | 33.688,73 | 2,27% | 33,1% |
|
SZSE:000513
Livzon Pharmaceutical Group
|
36.98 | 0% | 0% | 28.754,16 | 4,49% | 6,03% |
|
SZSE:002737
Sunflower Pharmaceutical Group
Co.,Ltd |
29.15 | 0% | 0% | 15.487,68 | 5,15% | 33,33% |
|
SHSE:600750
Jiang Zhong Pharmaceutical Co.,Ltd
|
22.77 | 0% | 0% | 10.158,64 | 6,02% | 6,79% |
|
SHSE:600812
North China Pharmaceutical Company.Ltd
|
5.20 | 0% | 0% | 8.887,48 | 0,19% | 0% |
|
SHSE:600664
Harbin Pharmaceutical Group
|
2.80 | 0% | 0% | 7.293,2 | 0% | 0% |
|
SZSE:000153
Anhui Fengyuan Pharmaceutical
|
8.70 | 0% | 0% | 2.838,82 | 1,72% | -3,78% |
|
NasdaqGM:UPC
Universe Pharmaceuticals INC
|
2.59 | 0% | 0% | 7,87 | 0% | 0% |
